Keyword

bone-modifying agents

Description: These are medications that alter bone resorption or formation, used particularly to prevent skeletal complications in cancer and other bone diseases.

Primary topic: Bone health and treatments (68%)

OpenAlex ID: keywords/bone-modifying-agents

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

2009 · Michael Gnant, Brigitte Mlineritsch, et al. · New England Journal of Medicine · 1,025

PDF

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

2011 · Michael Gnant, Brigitte Mlineritsch, et al. · The Lancet Oncology · 472

2019 · Noam Yarom, Charles L. Shapiro, et al. · Journal of Clinical Oncology · 420

American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

2011 · Catherine H. Van Poznak, Sarah Temin, et al. · Journal of Clinical Oncology · 342

PDF

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

2014 · M. Gnant, B. Mlineritsch, et al. · Annals of Oncology · 312

PDF

Management of Male Breast Cancer: ASCO Guideline

2020 · Michael J. Hassett, Mark R. Somerfield, et al. · Journal of Clinical Oncology · 263

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline

2017 · Sukhbinder Dhesy-Thind, Glenn G. Fletcher, et al. · Journal of Clinical Oncology · 222

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update

2017 · Catherine Van Poznak, Mark R. Somerfield, et al. · Journal of Clinical Oncology · 182

Cancer-associated bone disease

2013 · R. Rizzoli, J.-J. Body, et al. · Osteoporosis International · 148

PDF

Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw

2020 · Lina He, Xiangyu Sun, et al. · International Journal of Oral Science · 127

PDF

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

2022 · Andrea Eisen, Mark R. Somerfield, et al. · Journal of Clinical Oncology · 121

PDF

Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update

2018 · Kenneth Anderson, Nofisat Ismaila, et al. · Journal of Clinical Oncology · 119

Prevalence of hypercalcemia among cancer patients in the United States

2016 · Victor M. Gastanaga, Lee S. Schwartzberg, et al. · Cancer Medicine · 116

PDF

2018 · Japanese Study Group of Co-operative Dentistry with Medicine (JCDM), T. Hasegawa, et al. · Osteoporosis International · 97

Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients

2021 · Sakiko Soutome, Mitsunobu Otsuru, et al. · Scientific Reports · 83

PDF

Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer: An Updated Review

2023 · Koji Hatano, Norio Nonomura · The World Journal of Men s Health · 79

PDF

Severe hypercalcemia following denosumab treatment in a juvenile patient

2015 · Nokitaka Setsu, Eisuke Kobayashi, et al. · Journal of Bone and Mineral Metabolism · 79

Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer

2020 · Catherine H. Van Poznak, Joseph M. Unger, et al. · JAMA Oncology · 69

PDF

Psoralen inhibits bone metastasis of breast cancer in mice

2013 · Chunyu Wu, Zhenping Sun, et al. · Fitoterapia · 69

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures

2016 · Kenneth Pittman, Yoland C Antill, et al. · Asia-Pacific Journal of Clinical Oncology · 67

PDF

Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment.

2016 · Christian F Jehn, Ingo J Diel, et al. · PubMed · 63

Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review

2020 · Terry L. Ng, Megan M. Tu, et al. · Supportive Care in Cancer · 57

Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

2021 · Angel Qin, Songzhu Zhao, et al. · Journal of the National Comprehensive Cancer Network · 56

Virtual Management of Patients With Cancer During the COVID-19 Pandemic: Web-Based Questionnaire Study

2020 · Emad Tashkandi, Ahmed Zeeneldin, et al. · Journal of Medical Internet Research · 49

Progress in the treatment of bone metastases in cancer patients

2012 · Malgorzata Mackiewicz-Wysocka, Magdalena Pankowska, et al. · Expert Opinion on Investigational Drugs · 49

Works count: 635

Citation count: 7,498